Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mohammad Mehdi Etemadi"'
Publikováno v:
Reviews in Clinical Medicine, Vol 2, Iss 3, Pp 107-111 (2015)
Introduction: Human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis is a chronic progressive neurologic disease, which might be associated with brain and spinal cord atrophy and lesions. Here, we systemati
Externí odkaz:
https://doaj.org/article/5113308a6ee2448db48741e4ec41096b
Publikováno v:
ARYA Atherosclerosis, Vol 3, Iss 1 (2010)
Abstract INTRODUCTION: Transient ischemic attacks (TIA) are warnings of future stroke. There is no difference in risk factors, pathophysiology and prevention between TIA and brain infarction. methods: Consecutive patients with brain infarction admitt
Externí odkaz:
https://doaj.org/article/1eca0434180e4626a8e9846ca1306d9a
Autor:
Bita Khorram, Peyman Hashemi, Mahmoud Mahmoudi, Mahmoud Reza Azarpazhooh, Amin Amiri, Amir Azarpazhooh, Reza Farid Hosseini, Abdolrahim Rezaee, Mohsen Foroghipor, Naghmeh Mokhber, Mohammad Reza Abbaszadegan, Graham Taylor, Houshang Rafatpanah, Mohsen Tehrani, Leila Afsahr, Mohammad Mehdi Etemadi
Publikováno v:
Journal of Neuroimmunology. 250:87-93
Human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a chronic inflammatory myelopathy. The pathophysiology of HAM/TSP is not yet fully understood; therefore, effective therapy remains a challengi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a460f17177744d205bfe1675068c5579
https://doi.org/10.1016/j.jneuroim.2012.05.004
https://doi.org/10.1016/j.jneuroim.2012.05.004
Autor:
Faeze Sabet, Narges Valizade, Samane Sadat Hosseiny, Mohammad Mehdi Etemadi, Ali Shoeibi, Rosita Vakili, Reza Boostani, Bahare Fazeli, Seyed Abdolrahim Rezaee
Publikováno v:
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics. 12(4)
Considering that there is no effective treatment for human T-cell leukemia virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis, this study aimed to assess the impact of triple combination therapy—interferon-α, valproic acid, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bea309fb50b476a0f0836ef58aa74ef8
https://pubmed.ncbi.nlm.nih.gov/26174324
https://pubmed.ncbi.nlm.nih.gov/26174324
Autor:
Mahmoud Reza Azarpazhooh, Majid Ghayour-Mobarhan, Mohammad Reza Majdi, Naghmeh Mokhber, Amanda G. Thrift, Mohammad Taghi Farzadfard, Reza Kiani, Geoffrey A. Donnan, Majid Panahandeh, Kavian Ghandehary, Mohammad Mehdi Etemadi
Publikováno v:
Stroke. 41(1)
Background and Purpose— The epidemiology of stroke and its subtypes in the Middle East is unclear. Most previous studies have been performed in Western countries, and incidence rates are unlikely to apply in the Middle East. We aimed to determine t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::818a1d36f41ac45585055b4af535c96c
https://pubmed.ncbi.nlm.nih.gov/19926844
https://pubmed.ncbi.nlm.nih.gov/19926844
